160 likes | 292 Vues
This comprehensive review by Dr. Mark S. Freedman, a leading expert in neurology at the University of Ottawa, explores innovative approaches to enhancing treatment efficacy for relapsing-remitting multiple sclerosis (RRMS). It highlights recent advancements in therapies, the importance of personalized treatment plans, and ongoing research efforts to improve patient outcomes. Dr. Freedman's insights into the complexities of RRMS management aim to guide clinicians in optimizing care for their patients, ensuring sustainable long-term health.
E N D
1. Optimizing Treatment of Relapsing-Remitting MS Mark S. Freedman MSc MD FAAN FRCPC Professor of Neurology University of Ottawa Ottawa, Ontario CANADA